Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

68.29
Delayed Data
As of 4:00pm ET
 -0.12 / -0.18%
Today’s Change
49.96
Today|||52-Week Range
132.00
-27.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues66.7M47.2M50.6M41.1M
 
 
 
 
 
Depreciation And Amortization9.0M10.2M11.9M19.1M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses121.3M129.9M222.8M318.1M
 
 
 
 
 
Research And Development86.6M113.0M190.2M276.5M
 
 
 
 
 
Total Operating Expenses130.3M140.1M234.8M337.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-63.6M-92.9M-184.2M-296.0M
 
 
 
 
 
Extraordinary Charge-65.9M0.00-220.8M0.00
 
 
 
Pre-Tax Equity Earnings-4.5M0.000.000.00
 
 
Other Expenses16.4M-47.0K1.8M76.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-116.6M-91.9M-400.6M-290.1M
 
 
 
 
 
Income Taxes-10.6M-2.7M-40.2M0.00
 
 
 
 
Net Income-106.0M-89.2M-360.4M-290.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.3M61.6M74.3M84.0M
 
 
 
 
 
Shares To Calculate EPS Diluted50.3M61.6M74.3M84.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.11-$1.45-$4.85-$3.45
 
 
 
 
 
EPS Diluted-$2.11-$1.45-$4.85-$3.45